Sponsor

Cantargia AB

Clinical research sponsor

Published trials4

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

4 shown

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.NCT05181462 · lead sponsor · 2022-01-11

COMPLETED

A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid TumorsNCT05116891 · lead sponsor · 2021-09-22

COMPLETED

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsNCT04452214 · lead sponsor · 2020-09-24

COMPLETED

A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsNCT03267316 · lead sponsor · 2017-09-19

COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.